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Background
Many organs and tissue systems of  the body contain a portion of  
undifferentiated, multipotent progenitor cells. These cells can be 
stimulated to differentiate into specific lineages of  cells in the face 
of  physical or biological stimuli [1, 2]. These cells are located in-
different types of  tissues including bone marrow, skeletal muscle, 
and adipose tissue [1, 3, 4]. Recent research has focused on these 
cells ability to differentiate not only into their native tissue, but 
along other lineages as well [5-7].  
Fat grafting has long been utilized to fill in soft tissue defects both 
adjacent to the site of  harvest and at distant sites [8]. Adipose 
derived stem cells (ASCs) are easily acquired through liposuction 
techniques, and possess the ability to differentiate along multiple 
cell lineages [5, 9-11]. ASCs ease of  acquisition has led to intense 
research into their regenerative potential at the site of  large areas 
of  tissue loss [4]. Despite the higher yield and easier methods of  
harvest compared to other stem cell populations derived from 
muscle and bone marrow [12], ASCs number following initial 
harvest is often insufficient for bench, animal, or clinical experi-
ments, therefore in vitro expansion is often necessary [3, 13]. 
The amount of  in vitro expansion that these cells are subjected to 
is extremely variable and usually reported as a non-specific pas-
sage number [3, 13-19]. Dependent on the plating density and the 
confluence at which cells are harvested, the amount of  popula-
tion doublings (PDs) that a population of  ASCs undergoes before 
reaching confluence is extremely variable and are unknown from 
many publications. This leads to inconsistencies in the amount of  
time and thus number of  PDs that a cell population is subjected 
to before utilization in in vitro or in vivo models.
Previous research has demonstrated that as in vitro expansion of  
Abstract
Human adipose-derived stem cells (ASCs) are providing promise in clinical soft tissue replacement and repair. This study 
investigated the effect of  multiple population doublings (PD) on ASCs growth rates and cell specific differentiation capaci-
ties (DC) to evaluate potential inter-individual specimen growth rates and DC for in vitro cell expansion use in future clinical 
applications. A decreased cell growth rate and DC were observed in long term cell culture when PD reached to 10.1. Early 
PD specimens with PD range from 1.6 to 6.2 showed the average population doubling time (PDT) as 5.1 days. There was no 
significant difference in ASCs growth rates among individual specimens (n=4, p=0.184). The DC over PD range 1.6 to 6.2 
also showed no significant changes (osteogenic, n=3, p=0.472; chondrogenic, n=3, p=0.878; adipogenic, n=3, p=0.256). 
Our preliminary data showed the importance of  PD for in vitro ASCs expansion. The cell growth rate and DC of  ASCs 
were relatively stable up to PD 6.2. Beyond this PD, there was a trend of  decreased growth rate and DC. Therefore, our 
study suggested that future in vitro expansion of  ASCs for clinical application should consider limiting expansion of  ASCs to 
PD 6.2 or less to ensure the cell quality. Use of  specific PD instead of  the non-specific passage numbers would be a better 
standardization of  in vitro ASCs expansion for their clinical translational applications.
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ASCs is carried out for increasing time periods the cell population 
will exhibit both genetic and phenotypic changes [14, 16]. With 
increased passaging and the subsequently increased PDs, ASCs-
growth kinetics and ability to differentiate along varying cell line-
ages, or differentiation capacity (DC), is also affected [3, 14, 20].
Bieback et al., demonstrated that adipogenic differentiation rates 
were decreased with increased PD levels of  12-43.4 as compared 
to the baseline PD 4-5.7 [20]. 
Despite the huge regenerative potential ASCs present, human 
clinical trials have been limited [21]. One of  the biggest hurtle 
preventing the wide spread clinical application of  ASCs is the 
need to keep ASCs minimally manipulated prior to clinical ap-
plication. In the United States, the US U.S Food Drug Adminis-
tration (FDA) has authority over human cells, tissue, and cellular 
products, and thus over ASCs clinical use [22]. According to FDA 
regulations, homologous use of  a cell suspension has to be mini-
mally manipulated with little or no changes from the native cell 
phenotype [FDA 21 CFR 1271] which details testing, screening, 
shipping, and storage procedures. If  a cell or tissue product is ma-
nipulated beyond what is considered minimal, then it falls under 
the category of  a biologic drug which requires phase I, II, and III 
clinical trials and be granted a biological license [22]. This process 
can cost millions of  dollars and often requires years to complete. 
The ability to classify ASCs as a cell therapy under regulation 21 
CFR 1271 which is only subject to adherence togood manufactur-
ing guidelines greatly simplifies the process of  clinical application. 
Given the possibility and potential benefit of  maintaining ASCs 
as a ‘minimally manipulated’ cell population, standardization of  
the in vitro expansion that ASCs are subject to prior to future clini-
cal translational applications would be required.
This study specifically examined the effect of  PD on both PDT 
and DC with the goal of  establishing guidelines under which fu-
ture safe in vitro expansion can be undertaken prior to clinical 
application. 
Methods
Isolation and preparation of  ASCs
Following Cooper University Hospital Institutional Human Safety 
and Review Board approval and consent from individual patients, 
human adipose tissue was obtained from three subjects. Subjects 
were all female, aged 29 to 51 who underwent elective breast re-
duction or in the case of  one patient, elective thigh liposuction as 
well as breast reduction at Cooper University Hospital between 
August and October of  2015. Adipose tissue was obtained either 
via tumescent liposuction or en-bloc resection from the breasts 
of  two patients, and the breasts as well as the thigh of  the third 
patient. Any tissue obtained via en-block resection was minced 
whereas tissue harvested using liposuction was processed in its 
liquid/slurry form. All samples were washed with 37°C phos-
phate buffered saline (PBS) and weighed. The samples were incu-
bated in 0.1% type I Collagenase (Worthington, Lakewood, NJ) 
for one hour. Ten ml of  M199 with 10% fetal bovine serum (FBS) 
was added to inactivate the collagenase and the resulting cell sus-
pension was centrifuged at 1500 RPM, 4°C for 10 minutes. The 
resultant cell pellet was suspended in M199 (Cellgro, Manassas, 
VA) and centrifuged at 1200 RPM, 4°C for 5 minutes. This pellet 
was briefly (10 seconds) suspended in 1 ml sterile, double distilled 
water to rupture RBCs, followed by the addition of  M199 cell cul-
ture medium and filtered through a 100 µm filter and centrifuged 
at 800 RPM, 4°C for 5 minutes to obtain the stromal vascular 
fraction (SVF). An initial cell count of  the SVF was determined 
using hemocytometer. The SVF cells were then plated at 1 x 106 
in M199 (Gibco, Grand Island, NY) and10% FBS and incubated 
overnight at 37°C in 5% CO2 with room air. The next day, non-
adherent cells were washed away with PBS and the attached cells 
were collected using 0.25% trypsin-EDTA solution. These fresh 
isolated ASCs were transferred to new cell culture containers 
based on experimental design as described below.
Cell counting and cell population doubling
Freshly isolated ASCs were platedin triplicate at seeding densi-
ties of  500 cells/cm2, 1000 cells/cm2, 2500 cells/cm2, and 5000 
cells/cm2. These plated were then monitored daily using light mi-
croscopy and sub-cultured at 90% confluence. Total cell numbers 
were determined by hemocytometer. Cell population doubling 
(PD) was calculated using the following equation:
Cell number obtainedLn
Cell number seededPD=
Ln 2
 
 
 
Cell population doubling time (PDT) was calculated as below:
2 1( )PDT
PD
t t−
=
Where t1 and t2 are the beginning and end of  the exponential 
phase, respectively.
ASCs differentiation and assessing differentiation potential
A subgroup of  ASCs at different PD levels was subjected to os-
teogenic, adipogenic, and chondrogenic differentiation media. 
ASCs at 80%-90% confluency were incubated in StemPro® os-
teogenesis, adipogenesis, and chondrogenesis differentiation me-
dium (Invitrogen, Carlsbad, CA) for two to three weeks. Alizarin 
Red, Oil Red-O, and Alician blue dyes were used to assess osteo-
genic, adipogenic, and chondrogenic differentiation, respectively. 
Alizarin Red was added to fixed cells that had been cultured in os-
teogenic medium for at least 21 days. Oil Red-O and Alician blue 
dyes were added to cells that had been cultured for at least 14 days 
in adipogenic medium and chondrogenic medium, respectively. 
To extract the dye, different reagents where utilized to solubilize 
the target dye. Briefly, the Alizarin Red, Oil Red-O, and Alician 
blue dyes were extracted using 10% acetic acid, 100% isopro-
panol, and 6M guanidine hydrochloride, respectively. The optical 
density (OD) of  the extracted dye quantified using the following 
wavelengths: 405 nm for Alizarin Red, 495 nm for Oil Red-O, and 
595 nm for Alician blue. Fold changes between undifferentiated 
controls and differentiated samples were compared.
Data analysis
All experiments were performed with three repeats for each sam-
ple. The quantitative data were presented as mean ± standard er-
ror. Student’s t-test and ANOVA test were used to assess statisti-
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cal significance. A p-value of  ≤ 0.05 was considered significant 
for all experiments.
Results
Long term effect of  PD on ASCs cell growth and stem cell 
differentiation capability
One cell line was continuously cultured up to 99 days to measure 
the long-term effects of  PD on ASCs cell growth and stem cell 
differentiation capability (Figure 1). This cell line was examined at 
four different PD stages as PD2.2, PD5.0, PD8.0 and PD 10.1. 
The cell population doubling time (PDT) was used to evaluate cell 
growth rate. A high PDT indicated a slow cell growth rate. PDT 
at PD8.0 and PD10.1 were higher than PDT at PD2.2 and PD5.0 
(panel A). The stem cell differentiation capability was measured 
for adipogenic, osteogenic, and chondrogenic differentiations at 
PD 5.0 and PD 10.1 respectively. The representative staining im-
ages showed a declining trend of  staining at PD10.1 group than 
the PD5.0 group (panel B). Three individual cell cultures were 
performed at both PD groups for each differentiation and the 
intensity of  specific staining was used to quantify corresponding 
differentiation (panel C). The ratio of  Alizarin Red staining for 
osteogenic differentiation capability decreased from 5.6 to 1.8 (n 
= 3, p ≤ 0.001). The ratio of  Alician blue staining for chondro-
genic differentiation decreased from 2.4 to 1.3 (n = 3, p = 0.001), 
while the ratio of  Oil red-O staining for adipogenic differentia-
tion slightly changed from 1.6 to 1.4 (n = 3, p = 0.293). 
This pilot long-term study showed a negative effect of  higher PD 
(like 10.1) on ASCs cell growth and differentiation capabilities. 
Although only one cell line was studied in this experiment, there 
were triplicates for each sample and two differentiation capabili-
ties (osteogenic and chondrogenic) were decreased at PD10.1. 
The experimental plan was then to focus on the earlier PD ASCs 
populations to determine optimal expansion conditions in which 
osteogenic and chondrogenic changes were minimal compared to 
PD 0.
The short term effect of  PD on ASCs cell growth
Four freshly isolated ASCs were cultured at seeding density as 
500 cells/cm2, 1000 cells/cm2, 2500 cells/cm2, and 5000 cells/cm2 
respectively. Daily observations demonstrated that lower density 
seeded cells exhibited more spindle-like characteristics compared 
to those seeded at higher cell densities (Figure 2, panels A and 
B). The lower seeding densities required longer culture times for 
the cells to reach confluency. The 5000 cells/cm2 seeding den-
sity group required 12.3 days to become confluent with a cor-
responding cell PD of  1.6. The 2500 cells/cm2 seeding density 
group required 18.5 days to reach confluency with a PD of  3.8. 
The PD for the 1000 cells/cm2 and the 500 cells/cm2 seeding 
density groups were 4.9 and 6.2, respectively. The average PDT 
was 6.1 days for the 5000 cells/cm2 seeding group, 5.1 days for 
the 2500 cells/cm2 seeding group, 4.9 days for the 1000 cells/cm2 
seeding group and 6.2 days for the 500 cells/cm2 seeding group. 
No significant differences in ASCs growth rates among individual 
specimens were observed overall for PD 1.6-6.2 (n=4, p=0.184) 
Figure 1. The effect of  high population doubling number on the cell growth and differentiation capability of  Adipose-de-
rived stem cells (ASCs). One ASCs cell line was continuously sub-cultured for up to population doubling (PD) at 10.1. The 
effects of  PD on cell growth and differentiation capability were measured within the same cell line at different PD. Panel A: 
cell population doubling time at different PD number; Panel B: representative staining images for adipogenic, osteogenic, 
and chondrogenic differentiations at PD 5.0 and PD 10.1 respectively; Panel C: bar graph for quantified analysis of  ASCs 
differentiation capabilities at PD 5.0 and PD 10.1. For each differentiation, three individual measurements were done. Sig-
nificant decreases of  differentiation capabilities occurred for osteogenic differentiation(n = 3, p ≤ 0.001) and chondrogenic 
differentiation (n = 3, p = 0.001), while the change of  adipogenic differentiation was not significant (n = 3, p = 0.293). (* 
denotes values with statistical significance).
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(Figure 2, panel C).
The short term effect of  PD on ASCs cell differentiation ca-
pability
Three ASCs were subjected to differentiation media towards to 
adipose, osteocyte, or cartilage at different PD stages as seeding 
density influenced the PD levels when the respective cultures 
reached 80% confluence for analyses. Adipogenic differentia-
tion was evaluated by Oil red-O staining, a specific dye for lipid 
droplet (Figure 3, panel A). The Oil red-O staining intensities of  
adipogenic ASCs/undifferentiated ASCs were: 2.3 for PD 1.6; 2.8 
for PD 3.8; 3.9 for PD4.9; and 1.7 for PD6.2 (Figure 3, panel B). 
There was no statistical significance for ASCs adipogenic differ-
entiation rates at PD range from 1.6 to 6.2 (n=3, p=0.256).
ASCs differentiation for osteogenic and chondrogenic pheno-
types were evaluated by Alizarin Red staining and Alician blue 
staining, respectively (Figure 4 and 5). Representative images 
for osteogenic or chondrogenic differentiations at different PD 
groups were presented in panel A and quantified data for dif-
ferentiation capabilities in panel B. There were no statistically 
significant differences in either Alizarin Red staining or Alician 
blue staining across tested PD ranges. The Alizarin Red staining 
intensities of  osteogenic ASCs/undifferentiated ASCs were: 3.0 
for PD1.6; 2.2 for PD3.8; 2.8 for PD4.9; and 3.7 for PD6.2. There 
was no statistical significance for ASCs osteogenic differentiation 
in the PD range from 1.6 to 6.2 (n=3, p=0.472). The Alician blue 
staining intensities of  chondrogenic ASCs/undifferentiated ASCs 
were: 1.9 for PD 1.6; 1.8 for PD 3.8; 2.1 for PD4.9; and 2.1 for 
PD6.2. There was no statistical significance for ASCs chondro-
genic differentiation at PD range from 1.6 to 6.2 (n=3, p=0.878).
In summary, cell growth and stem cell differentiation capability 
results demonstrated no significant changes of  cell growth and 
differentiation rates for ASCs at PD range 1.6 to 6.2. 
Discussion
Stems cells role in tissues regeneration, specifically ASCs role, 
has gained significant interest. ASCs present a particular advanta-
geous stem cell population given ease of  harvest and increased 
yield compared to other stem cell populations. In the United 
States there is a large interest in the potential clinical applications 
of  ASCs, with countless articles published involving animal and 
in vitro experimentation. Though bone marrow derived stem cells 
have demonstrated intact DC following progressive in vitro expan-
sion [23], ASCs have been shown to be more sensitive in vitro as 
demonstrated in previous experiments [1, 14-16, 19]. A standard 
and practical guideline for in vitro ASCs expansion is required to 
standardize results among worldwide laboratories.  
Bieback et al., examined the effects of  ASCs replicative aging us-
ing PD in the presence of  human serum and fetal bovine serum 
on ASCs proliferation and adipogenic and osteogenic differentia-
tion rates [20]. They reported that the PD of  6 and above was 
associated with decreased adipogenic differentiation rates using 
PD 6.0 as baseline in both growth media. Using flow cytometric 
markers, there were no differences in cell surface makers for im-
munophenotypes at PD 6.0 compare PD 0. Mechanistic evidence 
demonstrated increased expression of  senescence markers were-
also associated with PD beyond 6.0. They concluded that human 
serum was comparable to fetal bovine serum in long-term ASCs 
growth cultures.
Our interest was to initially reproduce their finding of  diminished 
adipogenic differentiation rates associated with increased PD. 
In our one cell line subjected to long-term culture at PD > 6.2, 
phenotypic changes associated with increased senescence were 
Figure 2. The cell growth of  fresh isolated Adipose-derived stem cells (ASCs) at different seeding density.Panel A: repre-
sentative cell images at day 3 post-isolation; Panel B: representative ASCscell images at day 6 post-isolation; Panel C: bar 
graph of  data from four individual cell lines to show the population doubling time (PDT) which demonstrated no signifi-
cant differences for PD 1.6 - 6.2 (n=4, p=0.184).
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observed with significantly increased PDT. Our focus was then 
to understand the effects of  replicative aging in PD from 0-6 as 
FDA approved clinical application would most likely require that 
cultured and expanded ASCs would not have decreased adipo-
genic differentiation capacity. The goal would be to generate an 
expanded ASCs culture specimen that would have similar proper-
ties to a minimally manipulated autologous FDA approved ASCs 
preparation. 
Our short-term PD results demonstrated that ASCs populations 
Figure 3. Adipogenic differentiation capability of  Adipose-derived stem cells (ASCs) at different population doubling num-
ber. Panel A: representative images of  Oil Red-O staining; Panel B: bar graph of  analyzed Oil Red-O staining data from 
three cell lines, adipogenic differentiation capability was measured by the intensity of  Oil Red-O staining of  adipogenic 
differentiated ASCs (cultured by adipogenic medium) over un-differentiated ASCs (cultured by m199 medium).There were 
no significantdifferences demonstrated for ASCs adipogenic differentiation rates at PD range from 1.6 to 6.2 (n=3, p=0.256).
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PD 4.9 PD 6.2
A
Oil red O staining
B
Figure 4. Osteogenic differentiation capability of  Adipose-derived stem cells (ASCs) at different population doubling 
number. Panel A: representative images of  Alizarin Red staining; Panel B: bar graph of  analyzed Alizarin Red staining data 
from three cell lines, osteogenic differentiation capability was measured by the intensity of  Alizarin Red staining of  osteo-
genic differentiated ASCs (cultured by osteogenic medium) over un-differentiated ASCs (cultured by m199 medium).There 
were no significant differences demonstrated for ASCs osteogenic differentiation in the PD range from 1.6 to 6.2 (n=3, 
p=0.472).
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PD 4.9 PD 6.2
A
Alizarin red staining
Figure 5. Chondrogenic differentiation capability of  Adipose-derived stem cells (ASCs) at different population doubling 
number. Panel A: representative images of  Alician blue staining; Panel B: bar graph of  analyzed Alician blue staining data 
from three cell lines, chondrogenic differentiation capability was measured by the intensity of  Alician blue staining of  adi-
pogenic differentiated ASCs (cultured by chondrogenic medium) over un-differentiated ASCs (cultured by m199 medium).
There were no significant differences demonstrated for ASCs chondrogenic differentiation at PD range from 1.6 to 6.2 (n=3, 
p=0.878).
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may be expanded to a population doubling of  6.2 without any 
significant effect(s) on phenotypic growth rate or DC; beyond this 
PD level, increased PDT and decreased DC were demonstrated. 
Previous studies have demonstrated similar results which showed 
a trend towards increased passage numbers and decreased DC 
with increased in vitro culture [1, 14-16, 19, 20]. Comparing many 
previous studies which reported cell results as passage numbers 
compared to PD as in this study is difficult as the time to passage 
for most studies reported varies from 6 to 7 days with most PDTs 
for human ASCs reported in the 4 to 6 day range for passages 
less than 10. Comparing passage number to PD may be extrapo-
lated by assuming that a given ASCs cell line test undergoes ap-
proximately 1.3 PDs for each passage it is subjected to, and thus 
passage 10 for reported cell population corresponds to a PD of  
approximately 13. This is also variable due to tissue culture media 
conditions. 
In examining canine ASCs, Lee et al., [3] demonstrated signifi-
cantly increased PDT at PD greater than 6, with a trend towards 
increased PDT at lower PDs as well. In this study, there was also 
a dramatic decrease in DC with increasing PD. Di Battista et al., 
[1] demonstrated passage dependent osteogenic DC with human 
ASCs with almost complete phenotypic loss of  osteogenic dif-
ferentiation beyond PD 2. Interestingly, Di Battista also demon-
strated some variance in PDT up to passage 6 (PD not reported) 
but no significant change similar to results demonstrated with our 
experiments.
Wang et al., [19] found that ASCs showed no significant differ-
ence in DC along adipogenic and osteogenic lineages or in com-
mon surface markers up to passage 15 (PD not reported), but did 
find that cells have significantly decreased immunomodulatory 
effect in both an in vivo murine peritonitis model and in immu-
nomodulatory cytokine secretion at passage 3 compared to Pas-
sage 15. Their result lies in contrast to our results which showed 
decreased osteogenic DC beyond PD 6.1.
Safawani et al., [16] demonstrated preserved PDT at PD up to 15, 
but showed increased senesce markers and decreased DC along 
adipogenic and osteogenic lineages beyond PD 10. They con-
cluded that ASCs likely present decreased clinical utility beyond 
this PD 10.
ASCs growth rate was reported to remain constant in early PD 
and slower with increased cell passaging [14, 15]. A trend towards 
decreased DC along osteogenic and adipogenic DC was also dem-
onstrated universally.
As ASCs were cultured over long-time intervals, in addition to 
changes in PDT and PD discussed, phenotypic appearance 
changes were noted as well. Across all cells lines with PD of  
4 or greater, there was a noted transition to a more fibroblast 
like, spindle shaped phenotype. This characteristic has been ob-
served in previous studies examining long-term in vitro cultures 
of  ASCs, but the trend was even more pronounced in the cells 
initially seeded at lower seeding density (500 cells/cm2 and 1000 
cells/cm2) compared to higher seeding density (2500 cells/cm2 
and 5000 cells/cm2). There were no changes in DC or PDT for 
PD less than 6.2, but the fibroblast like phenotype was more evi-
dent at PD greater than 6.2.
Almost universally in bench, animal, and clinical experiments in 
which ASCs have been utilized, in vitro expansion is necessary 
to obtain a sufficient cell population prior to use [3, 13]. Future 
studies are needed to examine if  the type of  serum utilized effects 
ASCs phenotypical or genotypic expression. Also, future studies 
should examine and report in PD as opposed to nonspecific pas-
sage, to allow direct comparison of  results across studies. Another 
potential area for exploration involves the estimation of  ASCs 
yield for clinical application (see Table 1).
In a summary, no significant differences in growth rates or DC 
were observed among individual specimens and overall for in vit-
ro expansion of  ASCs up to PD 6.2. A trend towards decreased 
growth rates and DC were demonstratedwith greater than PD 6.2. 
Our data suggest that future ASCs clinical applications that re-
quire in vitro expansion may consider expanded ASCs up to but 
not exceed PD 6.2. Standardization of  in vitro expanded ASCs 
usage in clinical translational applications requires validation and 
use of  specific PD instead of  the non-specific passage numbers 
which are currently widely reported.
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